Clinical Trials
121 trialsStudy of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)
National Institutes of Health Clinical Center (CC)
Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
National Institutes of Health Clinical Center (CC)
Natural History Study of Patients With Neurofibromatosis Type 2
National Institutes of Health Clinical Center (CC)
Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas
OHSU Knight Cancer Institute
Three miRNA Signatures in Glioma: From Molecular Mechanisms to Potential Clinical Application
Regina Elena Cancer Institute
SC-Het-GM-CCS
The Children's Hospital of Zhejiang University School of Medicine
Natural History Study of Patients With Neurofibromatosis Type I
National Institutes of Health Clinical Center (CC)
GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM
Duke University
Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
National Institutes of Health Clinical Center (CC)
MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets
UNC Lineberger Comprehensive Cancer Center
Loupe-Based Intraoperative Fluorescence Imaging
University of Kentucky
ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes
Hackensack Meridian Health
EPICkids
Columbia University
Fast MRI
Karolinska University Hospital
Spectral Precise Image Study for Brain Tumors
Philips Clinical & Medical Affairs Global
NET-COMPARE
British Columbia Cancer Agency
Evaluation and Treatment of Neurosurgical Disorders
National Institutes of Health Clinical Center (CC)
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
National Institutes of Health Clinical Center (CC)
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
National Institutes of Health Clinical Center (CC)
A Natural History Study of Children and Adults With Olfactory Neuroblastoma
National Institutes of Health Clinical Center (CC)
Accuracy of Robotically Assisted Cranial Biopsies
Brainlab AG
Real-World Treatment Study of Koselugo (Selumetinib)
AstraZeneca
Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors
National Institutes of Health Clinical Center (CC)
Tumor Related Epilepsy
National Institutes of Health Clinical Center (CC)
Rare CNS Tumors Outcomes &Risk
National Institutes of Health Clinical Center (CC)
GliRecon
Johannes Kepler University of Linz
INFO SPINE
Metrosan End. ve Elk. Mek. Cihazlar ve Tibbi Malz. San. Tic. Ltd. Co.
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
University of Southern California
Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:
Xiangya Hospital of Central South University
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
National Institutes of Health Clinical Center (CC)
Cognitive Status After Removal of Skull Base Meningioma
Ohio State University
Multimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer
University of California, San Francisco
CSF-IMR
Medical University of Warsaw
Long-Term Longitudinal QoL in Patients Undergoing EEA
Ohio State University
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
M.D. Anderson Cancer Center
REVEAL
Ono Pharmaceutical Co., Ltd.
NEREUS
AstraZeneca
FET-BRAIN-DX
IRCCS San Raffaele
Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases
National Institutes of Health Clinical Center (CC)
LEARN
University of Sydney
MANGO
University of Sydney
Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
University of California, San Francisco
SHINE-GLIO
University Hospital, Essen
[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes
Telix Pharmaceuticals (Innovations) Pty Limited
VBS-CSI-PT-PED
Ruijin Hospital
Prospective Assessment of Quality of Life (QOL) in Pediatric Patients Treated With Radiation Therapy for Brain Tumors and Non-central Nervous System (Non-CNS) Malignancies
Massachusetts General Hospital
PEDIA
AstraZeneca
DOTATOC PET/CT for Imaging NET Patients
British Columbia Cancer Agency
Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks
Washington University School of Medicine